πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 22 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11980607

Methods of treating malignant lymphoproliferative disorders

ACTUATE THERAPEUTICS INC. Β· Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11885807

Method for depleting malignant T-cells

AUTOLUS LIMITED Β· Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11885806

Method for depleting malignant T-cells

AUTOLUS LIMITED Β· Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11510904

Methods of treating malignant lymphoproliferative disorders

ACTUATE THERAPEUTICS INC. Β· Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11385233

Methods of depleting malignant T-cells

AUTOLUS LIMITED Β· Granted Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10568901

Micro-RNA for the treatment of malignant solid tumors and metastasis

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10172937

Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies

Five Prime Therapeutics, Inc. Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9808505

Suppression of malignant mesothelioma by overexpression or stimulation of endothelial prot

The Board of Regents of the University of Texas System Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9242000

Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor gro

The Regents of the University of California Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8951971

Lymphatic zip codes in tumors and pre-malignant lesions

The Regents of the University of California Β· Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598316

Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or mali

The Regents of the University of California Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8536132

Lymphatic zip codes in tumors and pre-malignant lesions

The Regents of the University of California Β· Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919466

Lymphatic zip codes in tumors and pre-malignant lesions

The Regents of the University of California Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855191

Agent having a destructive effect on malignant tumors and method for the production thereo

C.Y.L. Pharmazeutika GmbH Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723474

Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or mali

The Regents of the University of California Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598341

Molecules that selectively home to vasculature of premalignant or malignant lesions of the

The Regents of the University of California Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354582

Use of VEGF antagonists for the treatment of malignant gliomas

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7118752

Compositions and methods for inhibiting the proliferation and invasiveness of malignant ce

UNIVERSITY OF CONNECTICUT Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6720344

Methods and compositions for stimulating osteoblast proliferation or treating malignant ce

The Board of Regents of the University of Texas System Β· Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6426076

Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and r

PASCO Pharmazeutische PrÀparate GmbH Β· Granted Tue Jul 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6299873

Method for improvement of radiation therapy of malignant tumors

UNIVERSITY OF CONNECTICUT Β· Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6214571

Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosin

The Regents of the University of California Β· Granted Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired